148 related articles for article (PubMed ID: 21089513)
1. [Fanconi anemia and DNA-damage response network].
Matsushita N; Kitao H; Ishiai M; Takata M
Tanpakushitsu Kakusan Koso; 2009 Mar; 54(4 Suppl):580-5. PubMed ID: 21089513
[No Abstract] [Full Text] [Related]
2. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
Wang W
Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
[TBL] [Abstract][Full Text] [Related]
4. New complexities for BRCA1 and BRCA2.
Kerr P; Ashworth A
Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
[TBL] [Abstract][Full Text] [Related]
5. [Fanconi anemia and genomic instability].
Kitao H; Fujinaka Y; Kubo N; Nakanoko T; Yoshinaga K; Tokunaga E; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
Fukuoka Igaku Zasshi; 2008 Jun; 99(6):115-22. PubMed ID: 18833937
[No Abstract] [Full Text] [Related]
6. Tracing the network connecting BRCA and Fanconi anaemia proteins.
Venkitaraman AR
Nat Rev Cancer; 2004 Apr; 4(4):266-76. PubMed ID: 15057286
[No Abstract] [Full Text] [Related]
7. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
Meetei AR; Medhurst AL; Ling C; Xue Y; Singh TR; Bier P; Steltenpool J; Stone S; Dokal I; Mathew CG; Hoatlin M; Joenje H; de Winter JP; Wang W
Nat Genet; 2005 Sep; 37(9):958-63. PubMed ID: 16116422
[TBL] [Abstract][Full Text] [Related]
8. Fanconi anemia (cross)linked to DNA repair.
Niedernhofer LJ; Lalai AS; Hoeijmakers JH
Cell; 2005 Dec; 123(7):1191-8. PubMed ID: 16377561
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
10. Biomedicine. D-Day for BRCA2.
Witt E; Ashworth A
Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
[No Abstract] [Full Text] [Related]
11. High-input biology.
Nat Genet; 2005 Sep; 37(9):913. PubMed ID: 16132040
[No Abstract] [Full Text] [Related]
12. The role of FAN1 nuclease in the Fanconi anemia pathway.
Castella M; Taniguchi T
Cell Cycle; 2010 Nov; 9(21):4259-60. PubMed ID: 21057200
[No Abstract] [Full Text] [Related]
13. Foci on fanconi.
Hoatlin M; Reuter T
Trends Mol Med; 2001 Jun; 7(6):237-9. PubMed ID: 11378500
[TBL] [Abstract][Full Text] [Related]
14. Hallmarks of 'BRCAness' in sporadic cancers.
Turner N; Tutt A; Ashworth A
Nat Rev Cancer; 2004 Oct; 4(10):814-9. PubMed ID: 15510162
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
[TBL] [Abstract][Full Text] [Related]
16. Repair pathways independent of the Fanconi anemia nuclear core complex play a predominant role in mitigating formaldehyde-induced DNA damage.
Noda T; Takahashi A; Kondo N; Mori E; Okamoto N; Nakagawa Y; Ohnishi K; Zdzienicka MZ; Thompson LH; Helleday T; Asada H; Ohnishi T
Biochem Biophys Res Commun; 2011 Jan; 404(1):206-10. PubMed ID: 21111709
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia and breast cancer susceptibility.
Patel KJ
Nat Genet; 2007 Feb; 39(2):142-3. PubMed ID: 17262024
[No Abstract] [Full Text] [Related]
18. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.
Dray E; Etchin J; Wiese C; Saro D; Williams GJ; Hammel M; Yu X; Galkin VE; Liu D; Tsai MS; Sy SM; Schild D; Egelman E; Chen J; Sung P
Nat Struct Mol Biol; 2010 Oct; 17(10):1255-9. PubMed ID: 20871616
[TBL] [Abstract][Full Text] [Related]
20. FANCD2 and DNA Damage.
Nepal M; Che R; Ma C; Zhang J; Fei P
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
